医学
氧化应激
发病机制
中医药
糖尿病
多元醇途径
肾脏疾病
活性氧
炎症
自噬
纤维化
糖基化
人参
肾
药理学
生物信息学
细胞凋亡
内科学
病理
内分泌学
醛糖还原酶
生物
生物化学
化学
替代医学
作者
Xiaoju Ma,Jinjin Ma,Tian Leng,Zhongzhu Yuan,Tingting Hu,Qiuyan Liu,Tao Shen
标识
DOI:10.1080/0886022x.2022.2146512
摘要
Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is complicated, and oxidative stress is considered as a core of DKD onset. High glucose can lead to increased production of reactive oxygen species (ROS) via the polyol, PKC, AGE/RAGE and hexosamine pathways, resulting in enhanced oxidative stress response. In this way, pathways such as PI3K/Akt, TGF-β1/p38-MAPK and NF-κB are activated, inducing endothelial cell apoptosis, inflammation, autophagy and fibrosis that cause histologic and functional abnormalities of the kidney and finally result in kidney injury. Presently, the treatment for DKD remains an unresolved issue. Traditional Chinese medicine (TCM) has unique advantages for DKD prevention and treatment attributed to its multi-target, multi-component, and multi-pathway characteristics. Numerous studies have proved that Chinese herbs (e.g., Golden Thread, Kudzuvine Root, Tripterygium glycosides, and Ginseng) and patent medicines (e.g., Shenshuaining Tablet, Compound Rhizoma Coptidis Capsule, and Zishen Tongluo Granule) are effective for DKD treatment. The present review described the role of oxidative stress in DKD pathogenesis and the effect of TCM intervention for DKD prevention and treatment, in an attempt to provide evidence for clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI